CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · IEX Real-Time Price · USD
53.37
-2.28 (-4.10%)
Apr 25, 2024, 1:21 PM EDT - Market open

CRISPR Therapeutics AG Market Cap

CRISPR Therapeutics AG has a market cap or net worth of $4.52 billion as of April 25, 2024. Its market cap has increased by 5.80% in one year.

Market Cap
4.52B
Enterprise Value
3.06B
1-Year Change
5.80%
Ranking
Category
Stock Price
$53.26

Market Cap Chart

Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $4.52B, an increase of 706.55%. That is a compound annual growth rate of 32.02%.

History

DateMarket Cap% Change
Apr 23, 20244.53B1.35%
Apr 22, 20244.47B1.11%
Apr 19, 20244.42B-1.98%
Apr 18, 20244.51B1.08%
Apr 17, 20244.46B-4.14%
Apr 16, 20244.65B-1.29%
Apr 15, 20244.71B-3.21%
Apr 12, 20244.87B-3.56%
Apr 11, 20245.05B1.90%
Apr 10, 20244.96B-5.29%
Apr 9, 20245.23B1.72%
Apr 8, 20245.14B1.89%
Apr 5, 20245.05B-3.32%
Apr 4, 20245.22B0.71%
Apr 3, 20245.19B-0.66%
Apr 2, 20245.22B-4.62%
Apr 1, 20245.47B0.03%
Mar 28, 20245.47B-2.85%
Mar 27, 20245.63B-1.14%
Mar 26, 20245.70B-0.15%
Mar 25, 20245.71B-0.74%
Mar 22, 20245.75B-3.88%
Mar 21, 20245.98B2.14%
Mar 20, 20245.86B1.36%
Mar 19, 20245.78B0.69%
View and export this data all the way back to 2016. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Grifols 5.30B
Bausch + Lomb 5.21B
Glaukos 5.07B
Halozyme Therapeutics 4.95B
R1 RCM 4.94B
Organon & Co. 4.73B
BridgeBio Pharma 4.70B
Doximity 4.59B
Market Cap Rankings